Define
You leave with a future-state operating model, a funded value case, and a roadmap your board can act on.
27+ yrs
of life sciences expertise
100+
transformation practitioners
20 of 20
top pharmaceutical companies served
Strategy built far from the work. Pharma's hardest questions sit where strategy meets operations. Transformation is fragmented, slow, and difficult to sustain. Strategy sits at a distance from customer and HCP reality. Strategy, technology and execution are split across partners, so accountability blurs. Momentum is lost between design and implementation. And value realization and adoption are addressed too late to change the outcome.
Generic consultants answer with frameworks. The frameworks have never met an MLR queue. The gap shows at implementation. Recommendations built without practitioner knowledge stall on compliance realities, entrenched systems, and people. The transformation slows to the speed of everything the deck did not know.
Programs are judged on whether new ways of working survive the transition, not on whether the platform went live. That moves change management to the start of the plan.
HCPs and patients now judge pharma against the best digital experience they have anywhere, not against other pharma. Deciding what the next engagement model should be is an evidence question before it is a channel question.
A portfolio of proofs of concept is ending as a strategy. The question leadership teams now ask is what the whole function looks like when intelligence runs inside every workflow. That is an architecture question, and it needs practitioners to answer it.
Transformation is increasingly bought as a single engagement from design through delivery, because the handoff between the firm that designed it and the teams left to deliver it is where the value leaks.
Every one of these is an operating question. We answer it through the expertise of people who have run the operation. We answer it with people who have run the operation.
You leave with a future-state operating model, a funded value case, and a roadmap your board can act on.
Insights from 6,020 HCPs show why trust, relevance, and simplicity must guide connected engagement.
A standardized CX program turned HCP feedback into actionable insights for content and channel optimization.
A customer-led benchmark exposed digital gaps, guided asset consolidation, and shaped a more cohesive CX strategy.
We design the future-state business and operating model and build the value case and roadmap that make it executable.
We measure what customers, HCPs and patients actually experience through CXQ® and our Excellence Maturity Assessments, and turn that evidence into an experience vision and investment priorities.
We run the governance, portfolio and program management that turns a roadmap into coordinated delivery, and track the benefits against the value case.
We prepare the organization, build capability, and measure adoption until the new ways of working are simply how the business runs.
Life sciences transformation consulting helps pharmaceutical, biotechnology, medical technology, and healthcare organizations redesign their operating models, capabilities, customer experiences, and ways of working.
Indegene connects transformation strategy with execution and adoption, helping organizations turn strategic ambition into measurable operational and business outcomes.
Transformation programs often lose value when strategy, technology, execution, and change management are handled separately.
Fragmented ownership creates handoffs, delays decisions, weakens accountability, and prevents new capabilities from achieving sustained adoption.
Successful execution requires a clear value case, future-state operating model, coordinated roadmap, strong governance, and accountability for outcomes.
Indegene brings these elements together in an integrated model that moves from enterprise design through implementation, adoption, and value realization.
Business and operating model design defines how an organization should structure its capabilities, processes, governance, technology, data, and teams to deliver its strategic objectives.
It translates enterprise strategy into an executable blueprint and roadmap for transformation.
Customer, HCP, and patient research reveals how stakeholders behave, what they need, and where existing experiences create friction.
These insights help organizations prioritize investments, design relevant capabilities, and align transformation with customer and business outcomes.
Transformation enablement converts a future-state vision into coordinated execution. It includes governance, portfolio management, program delivery, roadmap management, dependency management, and value tracking.
Its purpose is to maintain alignment between strategy and delivery while ensuring that transformation remains focused on measurable outcomes.
Adoption improves when change management begins early and remains integrated with transformation delivery.
Organizations must prepare affected teams, engage leaders and stakeholders, build new capabilities, measure adoption, and reinforce new behaviors until they become business as usual.
Traditional consulting firms often focus on strategy, design, or technology as separate engagements.
Indegene combines enterprise design, customer experience, execution and adoption with deep life sciences expertise - grounded in CXQ® research and our Excellence Maturity Assessments, and delivered by practitioners who have run the functions being redesigned. We remain accountable beyond strategy, through measurable value realisation.
Tell us where your transformation is losing momentum — the strategy that hasn't moved, the program without an owner, the platform nobody adopted. We'll bring practitioners who have run the work.
Benchmark your transformation maturity.